Background: Folate depletion has been implicated as a risk factor for neurodegenerative disorders. We hypothesized that transport of folate to the cerebrospinal fluid (CSF) compartment could be involved in the pathophysiology of these disorders.
Methods: The CSF/serum folate gradient (R(CSF/S)) was studied in 205 subjects with suspected cognitive disorder. Its relation to clinical and biochemical indices, including the integrity of the blood-CSF barrier, were characterized.
Results: In subjects who were diagnosed as nondemented (ND) the mean R(CSF/S )+/- SD was 2.46 +/- 0.62 versus 2.09 +/- 0.67 (p = 0.008) in the dementia subgroup with a vascular component (VaD + mixed). The ND subgroup had higher CSF folate (p = 0.001) and lower serum homocysteine values (p = 0.001) than the VaD + mixed subgroup. The folate gradient R(CSF/S) was negatively correlated with serum folate (p < 0.001, R(2) = 0.518) and to the albumin ratio, a blood-CSF barrier biomarker (beta = -0.235). The Alzheimer patients had R(CSF/S) and albumin ratios similar to the ND subjects.
Conclusion: The R(CSF/S) was significantly lower in the VaD + mixed dementia subgroup, suggestive of a defect in the transport of folate over the choroid plexus that seems to be characteristic of, and limited to, the VaD + mixed dementia subgroup.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000129696 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Statins for vascular dementia: A hype or hope.
Neuroscience
December 2024
Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour, 22511, AlBeheira, Egypt.
Article Synopsis
- Vascular dementia (VaD) is the second most common type of dementia after Alzheimer’s disease, characterized by cognitive impairment and memory loss, often linked to cerebral amyloid angiopathy (CAA).
- Early diagnosis and the use of anti-inflammatory treatments can potentially prevent the development of VaD, but there are currently no effective drugs available specifically for its management.
- Statins, commonly used for lowering cholesterol, may show promise in treating VaD and improving cognitive function, but the exact mechanisms of their effectiveness are still not well understood.
Curricular Self-management for patients on ventricular assist device support decreases depression: A multicenter randomized controlled trial.
Artif Organs
December 2024
Heart and Diabetes Center North-Rhine Westphalia, University Hospital of the Ruhr University Bochum, Bad Oeynhausen, Germany.
Article Synopsis
- Utilization of ventricular assist devices (VAD) for end-stage heart failure is advanced, but there's a need for evidence-based psychosocial support interventions post-implantation.
- A study in Germany involved 140 patients, randomly assigned to an intervention or control group, to evaluate the impact of a new VAD support curriculum on various health outcomes.
- Results indicated that while primary health complications were similar across both groups, the intervention significantly reduced depression in patients and showed improvements in anxiety, quality of life, social support, and self-management for those receiving the VAD intervention.
Model-Based Dose Identification of Dalbavancin for Long-Term Suppressive Outpatient Treatment of Ventricular Assist Device Infections.
Antibiotics (Basel)
November 2024
Hospital Pharmacy, Heidelberg University Hospital, Im Neuenheimer Feld 670, 69120 Heidelberg, Germany.
Increasing evidence suggests that dalbavancin is an effective long-term treatment for ventricular assist device (VAD) infections, with various prolonged dosing regimens currently in use. This retrospective study aimed to assess dalbavancin pharmacokinetics in VAD patients and identify optimal, feasible dosing regimens for long-term suppressive outpatient therapy. Data from Heidelberg University Hospital's VAD register were analyzed using non-linear mixed-effects modeling for pharmacokinetic analysis and dosing simulations (Lixoft).
View Article and Find Full Text PDFCepstral Peak Prominence in normophonic Irish-English speaking adults: The effect of gender, age, speech task segmental composition, recording conditions and CPP extraction method.
Clin Linguist Phon
November 2024
School of Linguistic, Speech and Communication Sciences, Trinity College Dublin, Dublin, Ireland.
This paper reports Cepstral Peak Prominence (CPP) values for normophonic English-speaking adults living in Ireland. A hundred vocally healthy adults (50 females, 50 males) aged 18-55 were audio recorded producing a series of speech tasks (sustained vowels, connected speech). Fifty-eight speakers in the 18-24 age group were recorded twice: remotely, using their mobile phones and onsite, in controlled recording setup.
View Article and Find Full Text PDFImpairment of Neurovascular Function in Intermediate Age-Related Macular Degeneration.
Transl Vis Sci Technol
November 2024
Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Australia.
Purpose: To investigate neurovascular function in eyes with age-related macular degeneration (AMD).
Methods: Subjects with bilateral large drusen (intermediate AMD) and healthy controls ≥50 years old were recruited. The vasculature within the central 6 × 6-mm retinal area was captured using optical coherence tomography angiography (OCTA) and segmented to return superficial plexus, deep plexus, choriocapillaris, and choroid.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!